Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis - PubMed (original) (raw)
Comparative Study
. 2011 Feb;122(2):414-22.
doi: 10.1016/j.clinph.2010.06.027. Epub 2010 Jul 24.
Affiliations
- PMID: 20659815
- DOI: 10.1016/j.clinph.2010.06.027
Comparative Study
Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis
Christian Krarup. Clin Neurophysiol. 2011 Feb.
Abstract
Objective: The diagnosis of amyotrophic lateral sclerosis (ALS) includes demonstration of lower motor neuron (LMN) and upper motor neuron (UMN) involvement of bulbar and spinal muscles. Electromyography (EMG) is essential to confirm LMN affection in weak muscles, and to demonstrate changes in clinically non-involved muscles. The aim of the study was to determine the relative importance of ongoing (active) denervation, fasciculations, chronic partial denervation with reinnervation at weak effort and loss of motor units at maximal voluntary contraction (MVC) in ALS.
Methods: EMG was carried out in weak and non-weak muscles in 220 patients suspected of ALS using concentric needle electrodes. Denervation activity and fasciculations in 966 muscles was quantified, the mean durations and amplitudes of motor unit potentials (MUPs) were compared to controls in 745 muscles, and the amplitudes and recruitment patterns at maximal voluntary effort were measured in 939 muscles. Twenty-five percent of patients had clinical involvement of 1 region, 42% of 2 regions and 33% of 3 regions. Clinically 65% had UMN involvement. Eighty-six percent of the patients had died on follow-up.
Results: Denervation activity occurred in 72% of weak muscles but in only 45% of non-weak muscles. Fasciculations occurred in 56% of weak muscles and in 65% of non-weak muscles. MUPs showed reinnervation in 87-91% of weak and non-weak muscles and in 44% of muscles neurogenic MUPs occurred in the absence of denervation activity. In patients with clinical involvement of 1 region, combined EMG criteria increased the number of affected regions in 93%, and in 40% of patients with clinical involvement of 2 regions EMG increased the number of involved regions.
Conclusions: Quantitative EMG confirmed widespread LMN involvement in patients with early ALS including clinically non-involved regions. These findings suggest that the maintenance of force is due to compensatory reinnervation in early disease and that this capacity may decline at later stages of ALS.
Significance: These findings support a recent consensus report (the Awaji criteria) that EMG should have equivalent weight to clinical manifestations to indicate LMN involvement. The findings strongly indicate that spontaneous activity is insufficient to show LMN involvement in non-affected muscles at early stages of disease, and that analysis of MUPs are needed to document the distribution of LMN involvement.
Copyright © 2010 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Comment in
- The EMG needle goes deeper in ALS.
de Carvalho M. de Carvalho M. Clin Neurophysiol. 2011 Feb;122(2):211-2. doi: 10.1016/j.clinph.2010.06.028. Epub 2010 Nov 12. Clin Neurophysiol. 2011. PMID: 21075049 No abstract available.
Similar articles
- Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis.
Körner S, Kollewe K, Fahlbusch M, Zapf A, Dengler R, Krampfl K, Petri S. Körner S, et al. Muscle Nerve. 2011 May;43(5):636-42. doi: 10.1002/mus.21936. Muscle Nerve. 2011. PMID: 21484822 - The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios' disease).
Cappellari A, Ciammola A, Silani V. Cappellari A, et al. Electromyogr Clin Neurophysiol. 2008 Mar;48(2):75-81. Electromyogr Clin Neurophysiol. 2008. PMID: 18435211 - Clinical utility of trapezius muscle studies in the evaluation of amyotrophic lateral sclerosis.
Cho JY, Sung JJ, Min JH, Lee KW. Cho JY, et al. J Clin Neurosci. 2006 Nov;13(9):908-12. doi: 10.1016/j.jocn.2006.01.044. Epub 2006 Oct 16. J Clin Neurosci. 2006. PMID: 17049243 - [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
Iwata NK. Iwata NK. Brain Nerve. 2007 Oct;59(10):1053-64. Brain Nerve. 2007. PMID: 17969345 Review. Japanese. - [Electroneuromyographic criteria of amyotrophic lateral sclerosis].
Pouget J. Pouget J. Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S34-4S42. Rev Neurol (Paris). 2006. PMID: 17128088 French.
Cited by
- Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis.
Colombo E, Doretti A, Scheveger F, Maranzano A, Pata G, Gagliardi D, Meneri M, Messina S, Verde F, Morelli C, Corti S, Maderna L, Silani V, Ticozzi N. Colombo E, et al. J Neurol. 2023 Jan;270(1):511-518. doi: 10.1007/s00415-022-11404-4. Epub 2022 Oct 2. J Neurol. 2023. PMID: 36183286 Free PMC article. - Longitudinal Quantitative MRI Evaluation of Muscle Involvement in Amyotrophic Lateral Sclerosis.
Paoletti M, Diamanti L, Muzic SI, Ballante E, Solazzo F, Foppoli L, Deligianni X, Santini F, Figini S, Bergsland N, Pichiecchio A. Paoletti M, et al. Front Neurol. 2021 Nov 24;12:749736. doi: 10.3389/fneur.2021.749736. eCollection 2021. Front Neurol. 2021. PMID: 34899571 Free PMC article. - Confocal Endomicroscopy of Neuromuscular Junctions Stained with Physiologically Inert Protein Fragments of Tetanus Toxin.
Roesl C, Evans ER, Dissanayake KN, Boczonadi V, Jones RA, Jordan GR, Ledahawsky L, Allen GCC, Scott M, Thomson A, Wishart TM, Hughes DI, Mead RJ, Shone CC, Slater CR, Gillingwater TH, Skehel PA, Ribchester RR. Roesl C, et al. Biomolecules. 2021 Oct 12;11(10):1499. doi: 10.3390/biom11101499. Biomolecules. 2021. PMID: 34680132 Free PMC article. - Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis.
Zakharova MN, Abramova AA. Zakharova MN, et al. Neural Regen Res. 2022 Jan;17(1):65-73. doi: 10.4103/1673-5374.314289. Neural Regen Res. 2022. PMID: 34100429 Free PMC article. - Characterization of Fasciculation Potentials (FPs) in Amyotrophic Lateral Sclerosis (ALS) and Peripheral Nerve Hyperexcitability Syndromes (PNH).
Wang H, Liu B, Tang J. Wang H, et al. Biomed Res Int. 2021 May 3;2021:6631664. doi: 10.1155/2021/6631664. eCollection 2021. Biomed Res Int. 2021. PMID: 33997032 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous